Related references
Note: Only part of the references are listed.Prognostic Significance of Serum PSA Level and Telomerase, VEGF and GLUT-1 Protein Expression for the Biochemical Recurrence in Prostate Cancer Patients after Radical Prostatectomy
Anna Gasinska et al.
PATHOLOGY & ONCOLOGY RESEARCH (2020)
Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up y
M. Pavel et al.
ANNALS OF ONCOLOGY (2020)
Expression of Glut-1 in Malignant Melanoma and Melanocytic Nevi: an Immunohistochemical Study of 400 Cases
Miroslav Dura et al.
PATHOLOGY & ONCOLOGY RESEARCH (2019)
The clinicopathologic impacts and prognostic significance of GLUT1 expression in patients with lung cancer: A meta-analysis
Bo Zhang et al.
GENE (2019)
The L-Type Amino Acid Transporter LAT1An Emerging Target in Cancer
Pascal Hafliger et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Competing Mortality in Patients With Neuroendocrine Tumors
Soon Khai Low et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2019)
Gastroenteropancreatic neuroendocrine neoplasms: selected pathology review and molecular updates
Siaw M. Chai et al.
HISTOPATHOLOGY (2018)
Glucose transporter-1 as an independent prognostic marker for cancer: a meta-analysis
Zheng-Xiao Zhao et al.
ONCOTARGET (2018)
Significance of Glucose Transporter Type 1 (GLUT-1) Expression in the Therapeutic Strategy for Pancreatic Ductal Adenocarcinoma
Hiroshi Kurahara et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
GSE1 predicts poor survival outcome in gastric cancer patients by SLC7A5 enhancement of tumor growth and metastasis
Keshuo Ding et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Amino acid transporters revisited: New views in health and disease
Palanivel Kandasamy et al.
TRENDS IN BIOCHEMICAL SCIENCES (2018)
Analysis of expression of the PD-1/PD-L1 immune checkpoint system and its prognostic impact in gastroenteropancreatic neuroendocrine tumors
Miguel Sampedro-Nunez et al.
SCIENTIFIC REPORTS (2018)
EZH2 Expression is increased in BAP1-mutant renal clear cell carcinoma and is related to poor prognosis
Chenmin Sun et al.
JOURNAL OF CANCER (2018)
GLUT1: A novel tool reflecting proliferative activity of lung neuroendocrine tumors?
Nazim Benzerdjeb et al.
PATHOLOGY INTERNATIONAL (2017)
Differential expression and prognostic significance of GLUT1 according to histologic type of non-small-cell lung cancer and its association with volume-dependent parameters
Young Wha Koh et al.
LUNG CANCER (2017)
Whole-genome landscape of pancreatic neuroendocrine tumours
Aldo Scarpa et al.
NATURE (2017)
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Biochemical Markers
Kjell Oberg et al.
NEUROENDOCRINOLOGY (2017)
Current treatment options for gastroenteropancreatic neuroendocrine tumors with a focus on the role of lanreotide
Beata Kos-Kudla et al.
WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY (2017)
Validity and clinical impact of glucose transporter 1 expression in colorectal cancer
Ghada M. K. GabAllah et al.
SAUDI JOURNAL OF GASTROENTEROLOGY (2017)
Genetic Disruption of the Multifunctional CD98/LAT1 Complex Demonstrates the Key Role of Essential Amino Acid Transport in the Control of mTORC1 and Tumor Growth
Yann Cormerais et al.
CANCER RESEARCH (2016)
Genetics of neuroendocrine tumors
Joakim Crona et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
Up-Regulation of LAT1 during Antiandrogen Therapy Contributes to Progression in Prostate Cancer Cells
Minhui Xu et al.
JOURNAL OF UROLOGY (2016)
Expression of glucose transporter-1 is correlated with hypoxia-inducible factor 1 and malignant potential in pancreatic neuroendocrine tumors
Minoru Fujino et al.
ONCOLOGY LETTERS (2016)
L-amino acid transporter 1 may be a prognostic marker for local progression of prostatic cancer under expectant management
Nobuyuki Yanagisawa et al.
CANCER BIOMARKERS (2015)
Prognostic significance of L-type amino acid transporter 1 (LAT1) expression in cutaneous melanoma
Akira Shimizu et al.
MELANOMA RESEARCH (2015)
L-type amino acid transporter 1 (LAT1) expression in lymph node metastasis of gastric carcinoma: Its correlation with size of metastatic lesion and Ki-67 labeling
Masaaki Ichinoe et al.
PATHOLOGY RESEARCH AND PRACTICE (2015)
High expression of L-type amino acid transporter 1 as a prognostic marker in bile duct adenocarcinomas
Nobuyuki Yanagisawa et al.
CANCER MEDICINE (2014)
LAT-1 functions as a promotor in gastric cancer associated with clinicopathologic features
Junqing Wang et al.
BIOMEDICINE & PHARMACOTHERAPY (2013)
Increased expression of system large amino acid transporter (LAT)-1 mRNA is associated with invasive potential and unfavorable prognosis of human clear cell renal cell carcinoma
Hironori Betsunoh et al.
BMC CANCER (2013)
Acidity Generated by the Tumor Microenvironment Drives Local Invasion
Veronica Estrella et al.
CANCER RESEARCH (2013)
Gene Expression of Glucose Transporter 1 (GLUT1), Hexokinase 1 and Hexokinase 2 in Gastroenteropancreatic Neuroendocrine Tumors: Correlation with F-18-fluorodeoxyglucose Positron Emission Tomography and Cellular Proliferation
Tina Binderup et al.
DIAGNOSTICS (2013)
The use of biomarkers in neuroendocrine tumours
Mohid Shakil Khan et al.
FRONTLINE GASTROENTEROLOGY (2013)
Glucose transporters in cancer metabolism
Kehinde Adekola et al.
CURRENT OPINION IN ONCOLOGY (2012)
HIF2α Acts as an mTORC1 Activator through the Amino Acid Carrier SLC7A5
Ainara Elorza et al.
MOLECULAR CELL (2012)
mTOR: from growth signal integration to cancer, diabetes and ageing
Roberto Zoncu et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2011)
Signaling Pathways Governing Tumor Angiogenesis
Toshiharu Sakurai et al.
ONCOLOGY (2011)
Genetic and Functional Studies Implicate HIF1α as a 14q Kidney Cancer Suppressor Gene
Chuan Shen et al.
CANCER DISCOVERY (2011)
The association of the angiopoietin/Tie-2 system with the development of metastasis and leukocyte migration in neuroendocrine tumors
Nicte Figueroa-Vega et al.
ENDOCRINE-RELATED CANCER (2010)
LAT1 expression in non-small-cell lung carcinomas: Analyses by semiquantitative reverse transcription-PCR (237 cases) and immunohistochemistry (295 cases)
Katsuyuki Takeuchi et al.
LUNG CANCER (2010)
Structural and biological properties of a papillary component generating a micropapillary component in lung adenocarcinoma
Tatsuya Nagano et al.
LUNG CANCER (2010)
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
G. L. Semenza
ONCOGENE (2010)
Pancreatic Endocrine Microadenomatosis in Patients With von Hippel-Lindau Disease
Martine Pé rigny et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2009)
Bidirectional Transport of Amino Acids Regulates mTOR and Autophagy
Paul Nicklin et al.
CELL (2009)
VHL inactivation is an important pathway for the development of malignant sporadic pancreatic endocrine tumors
A. M. Schmitt et al.
ENDOCRINE-RELATED CANCER (2009)
GLUT1 as a therapeutic target in hepatocellular carcinoma
Thomas Amann et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2009)
Euphorbiae humifusae induces apoptosis in Hep3B hepatocarcinoma cells via simultaneous activation of the death receptor-mediated and mitochondrial pathways
Sang Ho Seo et al.
MOLECULAR MEDICINE REPORTS (2009)
l-type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms
Kyoichi Kaira et al.
CANCER SCIENCE (2008)
One hundred years after Carcinoid: Epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States
James C. Yao et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
6-L-F-18-fluorodihydroxyphenylalanine PET in neuroendocrine tumors: Basic aspects and emerging clinical applications
Pieter L. Jager et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Expression of L-type amino acid transporter 1 (LAT1) in neuroendocrine tumors of the lung
Kyoichi Kaira et al.
PATHOLOGY RESEARCH AND PRACTICE (2008)
Inhibition of system L (LAT1/CD98hc) reduces the growth of cultured human breast cancer cells
David B. Shennan et al.
ONCOLOGY REPORTS (2008)
Genome-wide resources of endoribonuclease-prepared short interfering RNAs for specific loss-of-function studies
Ralf Kittler et al.
NATURE METHODS (2007)
Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: Novel pathways and targets for anticancer therapeutics
Rachel E. Airley et al.
CHEMOTHERAPY (2007)
Expression of the pro-angiogenic factors vascular endothelial growth factor and interleukin-8/CXCL8 by human breast carcinomas is responsive to nutrient deprivation and endoplasmic reticulum stress
Philip L. Marjon et al.
MOLECULAR CANCER (2004)
Share Paper
